Eton Pharmaceutcials
ETON
47 hedge funds and large institutions have $70.3M invested in Eton Pharmaceutcials in 2020 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 26 increasing their positions, 6 reducing their positions, and 3 closing their positions.
333% more repeat investments, than reductions
Existing positions increased: 26 | Existing positions reduced: 6
267% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 3
28% more capital invested
Capital invested by funds: $54.9M → $70.3M (+$15.3M)
21% more funds holding
Funds holding: 39 → 47 (+8)
2.48% more ownership
Funds ownership: 33.57% → 36.04% (+2.5%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$3.09M |
| 2 |
AIC
AWM Investment Company
New York
|
+$2.7M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.35M |
| 4 |
Two Sigma Investments
New York
|
+$976K |
| 5 |
HRCM
Hood River Capital Management
Palm Beach Gardens,
Florida
|
+$589K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Russell Investments Group
London,
United Kingdom
|
-$352K |
| 2 |
MAM
Martingale Asset Management
Boston,
Massachusetts
|
-$91K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$90K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$89.7K |
| 5 |
PPA
Parametric Portfolio Associates
Seattle,
Washington
|
-$16.8K |
ETON Hedge Fund Activity: Q4 2020 in Review
47 of the 5,676 institutional investors tracked by Wall St. Rank reported a position in Eton Pharmaceutcials (ETON) for Q4 2020, worth a combined $70.3M — up 28% from $54.9M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new ETON positions and 3 closed out — a net gain of 8 holders — while 26 added to existing stakes and 6 trimmed.
The largest buyer was Opaleye Management, adding an estimated $3.09M. The largest seller was Russell Investments Group, cutting an estimated $352K.
- 47 institutional investors held Eton Pharmaceutcials (ETON) as of Q4 2020, up from 39 in Q3 2020.
- Funds reported $70.3M of Eton Pharmaceutcials stock for Q4 2020, up 28% quarter-over-quarter.
- 11 funds opened new Eton Pharmaceutcials positions in Q4 2020 and 3 closed out, a net change of +8 holders.
- The largest Eton Pharmaceutcials buyer in Q4 2020 was Opaleye Management, an estimated $3.09M added.
- The largest Eton Pharmaceutcials seller in Q4 2020 was Russell Investments Group, an estimated $352K sold.
Based on aggregated 13F filings for Q4 2020.